Kelsi Dixon
Family · Estero, FLNPI 1427597145
Payments from drug & device makers
Across 325 payments — averaging $20.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Johnson & Johnson$903
- Galderma Laboratories, L.p.$718
- Novartis$573
- Sun Pharmaceutical Industries Inc.$493
- Sanofi$445
- plus $2K from 20 others
What the payments were for
- Consulting fees$6009%
- Food & beverage$5,30180%
- Education$73311%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 93 | $1,524 |
| Johnson & Johnson | 62 | $903 |
| Galderma Laboratories, L.p. | 6 | $718 |
| Novartis | 39 | $573 |
| Sun Pharmaceutical Industries Inc. | 16 | $493 |
| Sanofi | 18 | $445 |
| Regeneron Healthcare Solutions, Inc. | 21 | $429 |
| Lilly USA, LLC | 15 | $373 |
| Pfizer | 12 | $227 |
| Amgen | 9 | $187 |
| Sanofi-aventis U.S. LLC | 2 | $130 |
| UCB, Inc. | 6 | $121 |
| Incyte Corporation | 3 | $65 |
| Dermavant Sciences, Inc. | 2 | $60 |
| Biofrontera Inc. | 4 | $58 |
| Organogenesis Inc. | 3 | $53 |
| LEO Pharma Inc. | 3 | $45 |
| Arcutis Biotherapeutics, Inc. | 2 | $42 |
| E.r. Squibb & Sons, L.L.C. | 2 | $40 |
| Organon | 1 | $32 |
| Almirall LLC | 1 | $25 |
| VYNE Pharmaceuticals Inc. | 1 | $20 |
| Mayne Pharma Commercial LLC | 1 | $20 |
| Paratek Pharmaceuticals, Inc. | 1 | $19 |
| Merz North America, Inc. | 1 | $17 |
| Sandoz | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,634 in reported general payments places this provider in the 95th percentile of 14,618 family providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 29 | $118,176 |
| Dupixent SyringeDupilumab | 15 | $66,194 |
| Fluorouracil | 84 | $5,667 |
| Clobetasol Propionate | 108 | $5,187 |
| Ketoconazole | 210 | $3,184 |
| Fluocinonide | 51 | $2,004 |
| Triamcinolone Acetonide | 157 | $1,125 |
| Betamethasone Dipropionate | 26 | $936 |
| Metronidazole | 13 | $853 |
| Ciclopirox | 26 | $626 |
| Hydrocortisone | 81 | $462 |
| Doxycycline Hyclate | 35 | $321 |
| Clindamycin Phosphate | 15 | $299 |
| ValacyclovirValacyclovir Hcl | 25 | $239 |
| Mupirocin | 27 | $198 |
Paid to pharmacies, not to this prescriber.
Other family in Estero
- John HuffakerVenice$8M
- Stephanie MompointMiami$4.5M
- Miguel TrujilloMiami Gardens$4.4M
- Itsel Cardenas RamonMiami$1M
- Lewis HarringtonTampa$954K
- Adam StrosbergFort Lauderdale$859K
- Danielle PharesFt Lauderdale$713K
- David RodriguezHialeah$658K
- Donna OrtizOrlando$417K
- Patrick SzarazMiami$327K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.